Patent Number: 6165783
Date of First Priority Issue: Friday October 24th, 1997
Date Issued: Tuesday December 26th, 2000
Assignee: Neuro Spheres Holdings Ltd. (Calgary, CA)
Inventors: Weiss, Samuel (Calgary, CA); Sorokan, S. Todd (Victoria, CA)
EPO is used clinically for treatment of anemia and is considered generally safe. This patent teaches that administration of EPO can stimulate the differentiation of neurons. Currently this concept is being tested (at least in part) by Stem Cell Therapeutics who are conducting clinical trials using EPO together with hCG for the treatment of stroke.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking: